tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market
Advertisement

Crescent Biopharma (CBIO) Cash flow

Compare
990 Followers

Crescent Biopharma Cash Flow

CBIO's free cash flow for Q3 2025 was $-18.11M. For the 2025 fiscal year, CBIO's free cash flow was decreased by $3.79M and operating cash flow was $-17.52M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -31.10M$ -34.88M$ -46.46M$ -57.49M$ -39.24M
Investing Cash Flow
$ 20.03K$ -21.39K$ -84.19K$ -14.94K$ -68.51K
Financing Cash Flow
$ 5.40K$ 28.82M$ 4.16M$ 10.72M$ 18.14M
End Cash Position
$ 10.72M$ 41.79M$ 47.87M$ 90.25M$ 137.04M
Free Cash Flow
$ -31.11M$ -34.90M$ -46.54M$ -57.50M$ -39.31M
Currency in USD

Crescent Biopharma Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis